Metabolic-dysfunction-associated steatotic liver disease (MASLD) arises from excessive intrahepatic triglyceride accumulation ...

Presentations highlight relationship between semaglutide and blood markers of gene modification age predictors, gut bacteria, ...

Fragmented sleep is associated with the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD).

Globally, more than 30% of the adult population has metabolic dysfunction-associated steatotic liver disease (MASLD). People ...

A new study published in the journal of Nature Scientific Reports showed that the patients with hypothyroidism have increased ...

A study published in Nature Aging has revealed a promising new drug candidate that may help combat metabolic dysfunction-associated steatotic liver disease (MASLD), a chronic liver condition that ...

A modeling study predicts a substantial rise in MASLD prevalence and associated liver-related complications in the United ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD) ...

A large population-based cohort study reports that using GLP-1 RAs significantly reduces the risk for cardiovascular events ...

Michelle Tratchenberg, 39, had received a liver transplant in the months leading up to her death. While a cause of death has ...

Alcoholic and non-alcoholic fatty liver disease (NAFLD) are well-known risk factors for colorectal cancer (CRC). NAFLD has ...

Almost one in three adults worldwide suffers from fatty liver disease, also known as metabolic dysfunction-associated fatty liver disease (MASLD). MASLD can lead to serious liver diseases such as ...